All Articles

StatSocial's new Substack integration gives marketers unprecedented access to the newsletter economy's valuable, high-intent audiences. What does it mean?

A new injectable dye entering Phase 3 trials promises to make lung cancer cells glow, helping surgeons remove tumors more completely and prevent recurrence.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

Consumers overcharged for generic drugs may get cash from a new $17.8M settlement. Find out if you're eligible and how this fits into a larger legal war.

A leader in oil spill response since 1960, SLICKBAR® has won two major awards, underscoring its vital role in tackling environmental emergencies.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

Boston-based PhaseV unveils its AI Conductor, a new platform designed to automate the entire clinical trial lifecycle and accelerate FDA submissions.

A new SHEIN survey reveals Gen Z's multi-outfit festival craze. But as the fast-fashion giant cashes in, its strategy faces mounting ethical scrutiny.

Zillow partners with top brokerages to launch Preview, a new tool making 'coming soon' homes public, aiming to end the era of secret pocket listings.

Primaris REIT hires investment veteran Julian Schonfeldt to lead an aggressive growth strategy, focusing on acquisitions and unlocking value from former department store sites.

Akur8 expands into life insurance by acquiring Slope Software, signaling a major shift in the actuarial tech landscape toward unified, AI-driven platforms.

After regaining Nasdaq compliance, Incannex Healthcare is leveraging its $75M war chest to advance novel treatments for sleep apnea and anxiety.

A new device acts as a security system for your air, monitoring invisible threats like mold. But can consumer tech truly deliver on this bold promise?

Belgian firm Endo Tools Therapeutics wins US approval for its next-gen endomina® EZFuse, a device promising to cut GI procedure times by up to 50%.

This April, Greek Wine Week returns to Toronto, challenging old stereotypes with a new generation of world-class wines and indigenous grapes.

A new collaboration will use Voro's 'masking' technology to create tumor-activated ADCs, aiming to make powerful cancer therapies safer and more effective.

A new report reveals homebuyers face nearly $32,000 in unexpected costs, 4x more than planned, leading to widespread financial strain and regret.

As a global operator exits, a Vancouver hotel relaunches with local control, offering a timely solution to the city's looming FIFA World Cup housing crunch.

In a major geopolitical shift, the U.S. is financing a massive nuclear fuel export to South Korea, aiming to break Russia's market grip and power the future.

Brazil's largest holding company announces a historic 11% profit increase, a 59% shareholder return, and massive payouts, all amid high interest rates.